Follow-up after successful treatment for developmental dysplasia of the hip using a Pavlik harness : is two years

Jessica P J Larwood1, Opeyemi Idowu1, Kirsten G B Elliott1

  • 1Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

PubMed

Insights

Children successfully treated for developmental dysplasia of the hip (DDH) with a Pavlik harness can be discharged at age two if findings are normal. This study confirms no relapses occurred by age five in these cases.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Dysplasia of the Hip (DDH)
  • Pavlik Harness Treatment

Background:

  • The optimal follow-up duration for children successfully treated for DDH using a Pavlik harness is not well-established.
  • Uncertainty exists regarding when to safely discontinue routine clinical and radiological monitoring.

Purpose of the Study:

  • To determine if children with DDH, treated successfully with a Pavlik harness and showing normal clinical/radiological findings at age two, can be discharged from routine follow-up.
  • To assess the long-term outcomes up to age five in this patient cohort.

Main Methods:

  • Prospective data collection on 101 children (170 hips) treated with a Pavlik harness between 2015-2016.
  • Radiographs (hip AP) were taken at ages one, two, and five years.
  • Normal hip radiography defined by acetabular index, symmetrical ossific nuclei, IHDI grade 1, and CEA > 20°.

Main Results:

  • 92% (157/170 hips) demonstrated normal radiological findings at age two.
  • All hips that were normal at age two remained normal at age five.
  • Children with normal findings at age two experienced no further interventions or relapses by age five.

Conclusions:

  • Successful Pavlik harness treatment for DDH allows for safe discharge from routine follow-up at age two years.
  • This recommendation applies to children with normal clinical and radiological assessments at the two-year mark.
  • Discharging patients earlier can optimize healthcare resource allocation.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...